NS
IGMS

NBC Securities’s IGM Biosciences IGMS Stock Holding History

NBC Securities’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-450
Closed -$7K – 1644
2024
Q3 		$7K Sell
450
-50
-10% -$548 ﹤0.01% 1824
2024
Q2 		$3K Buy
500
+350
+233% +$3K ﹤0.01% 1938
2024
Q1 		$1K Hold
150
– – ﹤0.01% 2087
2023
Q4 		$1K Hold
150
– – ﹤0.01% 2065
2023
Q3 		$1K Buy
+150
New +$1.27K ﹤0.01% 2069

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NBC Securities's IGMS Position: Q4 2024 in Review

NBC Securities sold out of IGM Biosciences (IGMS) in Q4 2024, closing a stake of 450 shares — an estimated $7K sold.

NBC Securities first reported a position in IGMS in Q3 2023 and held it in 5 quarters. The position peaked at $7K in Q3 2024. 85 funds tracked by Wall St. Rank hold IGMS as of Q4 2024.

  • NBC Securities reported no remaining IGM Biosciences position as of Q4 2024 after selling out during the quarter.
  • NBC Securities sold 450 IGM Biosciences shares in Q4 2024, an estimated $7K.
  • NBC Securities first reported a position in IGM Biosciences in Q3 2023 and held it in 5 quarters.
  • NBC Securities's IGM Biosciences position peaked at $7K in Q3 2024.
  • 85 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2024.

Based on NBC Securities's 13F filing for Q4 2024, filed 22 Jan 2025.